A significantly higher mortality rate in breast cancer than in lung cancer worldwide raises serious concerns despite advances in biomarker research and diagnosis. Conventional chemotherapeutics are usually associated with poor tumor selectivity, multi-drug resistance, adverse effects due to the conventional route of ad...
Ashadul Hoque, Shubhrajit Mantry, A. Bhunia et al.· International journal of pha...· 0 citations
Metabolic dysfunction-associated fatty liver disease (MAFLD) is commonly accompanied by chronic low-grade inflammation. The Aggregate Index of Systemic Inflammation (AISI) is an accessible inflammatory marker, while the Healthy Nordic diet may have favorable metabolic effects. This study investigated relationships amon...
Amr A. El-Sehrawy, Ismail Kandil, G. Elmazny et al.· Scientific Reports· 0 citations
Non-alcoholic fatty liver disease (NAFLD) is a common metabolic condition characterized by hepatic steatosis and chronic low-grade inflammation, with oxidative stress playing a pivotal role in its progression. The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an accessible marker reflecting systemic inflamm...
Amr A. El-Sehrawy, Ahmed M. Salah, Ismail Kandil et al.· Scientific Reports· 0 citations
Growing evidence suggests that composite metabolic indices may offer valuable insights into obesity-related complications. The Cardiometabolic Index (CMI), a surrogate marker of adverse lipid profiles and central adiposity, has emerged as a promising indicator of cardiometabolic risk. Nevertheless, its association with...
Amr A. El-Sehrawy, Ismail Kandil, M. Maashi et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.